99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents

Bioconjugate Chemistry

Volumn 12, Issue 6, 2001, Pages 1028-1034

  Langer, M ^a,b   La Bella, R ^c   Garcia Garayoa, E ^c   Beck Sickinger, A G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b ETH ZURICH   (Switzerland)

^c PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; CELL CULTURE; CHELATION; MAMMALS; PLASMA STABILITY; SYNTHESIS (CHEMICAL); TUMORS;

AMINO ACID PEPTIDES; BINDING AFFINITIES; CELL LINES; CENTRAL NERVOUS SYSTEMS; NEUROBLASTOMAS; NEUROPEPTIDE Y; NEUROPEPTIDES; PANCREATIC POLYPEPTIDES; PERIPHERAL NERVOUS SYSTEM; TUMOR IMAGING AGENTS;

PEPTIDES;

CROSS LINKING REAGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; LIGAND; NEUROPEPTIDE Y; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BINDING COMPETITION; DRUG STABILITY; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; MOUSE; NEOPLASM; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; BINDING, COMPETITIVE; CROSS-LINKING REAGENTS; DRUG STABILITY; INJECTIONS, INTRAVENOUS; LIGANDS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; NEOPLASMS; NEUROPEPTIDE Y; RADIOPHARMACEUTICALS; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 0034747366     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc015514h     Document Type: Article

References (39)

1. The relationship existing between chemical constitution, distribution, and pharmacological action
2. Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging
3. Diagnostic applications of radiolabeled peptides in nuclear endocrinology
4. Radio-labeled receptor-binding peptides: A new class of radiopharmaceuticals
5. Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy
6. Pharmacokinetic considerations in the development of peptide-based imaging agents
7. Studies on radiolabeled somatostatin analogues in rats and in patients
8. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients
9. Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy
10. In vitro and in vivo evaluation of a 99m-Tc(I)-tricarbonyl labeled high affinity bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors
11. 123I-vasoactive intestinal peptide (VIP) receptor scanning: Update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract
12. Peptides as carrier for tumor diagnosis and treatment
13. Neuropeptide Y: Complete amino acid sequence of the brain peptide
14. XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
15. Structure - Activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors
16. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family
17. Potential technetium small molecule radiopharmaceuticals
18. A novel organometallic aqua complex of technetium for the labeling of biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in aqueous solution and its reaction with a bifunctional ligand
19. The first selective agonist at the neuropeptide Y Y5-receptor increases food intake in rats
20. Synthesis of a branched cyclic peptide using a strategy employing FMOC chemistry and two additional orthogonal protecting groups
21. Comparison of the stability of technetium-labeled peptides to challenge with cysteine
22. Novel peptide conjugates for tumor-specific chemotherapy
23. Tumor pretargeting: Role of avidin/streptavidin on monoclonal antibody internalization
24. Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC
25. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of(99m)Tc(I)-tricarbonyl complexes: A hint for the future functionalization of biomolecules
26. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line
27. [Leu31, Pro34]-neuropeptide Y: A specific Y1 receptor agonist
28. Neuropeptide Y: Identification of the binding site
29. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals
30. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex
31. Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity
32. Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides
33. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations
34. Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16
35. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man
36. Neuropeptide Y receptor subtypes, Y1 and Y2
37. Peptide YY receptor distribution and subtype in the kidney: Effect on renal hemodynamics and function in rats
38. Cheracterization of receptor types for neuropeptide Y and related peptides